{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:33:39Z","timestamp":1783398819061,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015803","name":"BC Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ijrobp.2021.10.149","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T11:04:19Z","timestamp":1636369459000},"page":"861-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association Between Regional Nodal Irradiation and Breast Cancer Recurrence-Free Interval for Patients With Low-Risk, Node-Positive Breast Cancer"],"prefix":"10.1016","volume":"112","author":[{"given":"Daegan","family":"Sit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafisha","family":"Lalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Speers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovedeep","family":"Gondara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Gelmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Lohrisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4146-881X","authenticated-orcid":false,"given":"Alan","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.10.149_bib0001","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0002","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.SABCS18-GS4-02","article-title":"Regional lymph node irradiation in early stage breast cancer: An EBCTCG meta-analysis of 13,000 women in 14 trials","volume":"79","author":"Dodwell","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0003","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0004","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(98)09201-0","article-title":"Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial","volume":"353","author":"Overgaard","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0005","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1200\/JCO.2009.24.9284","article-title":"Breast cancer subtypes and the risk of local and regional relapse","volume":"28","author":"Voduc","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0006","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1200\/JCO.2011.36.1105","article-title":"Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy","volume":"29","author":"Arvold","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0007","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","article-title":"Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer","volume":"24","author":"Haffty","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0008","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10549-015-3352-0","article-title":"Retrospective analysis of metastatic behaviour of breast cancer subtypes","volume":"150","author":"Savci-Heijink","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0009","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1373\/clinchem.2006.076497","article-title":"Analytical validation of the oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer","volume":"53","author":"Cronin","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41523-018-0082-6","article-title":"Clinical relevance of the 21-gene Recurrence Score (R) assay in treatment decisions for patients with node-positive breast cancer in the genomic era","volume":"4","author":"Mamounas","year":"2018","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0011","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2019.5559","article-title":"Association between 21-gene assay recurrence score and locoregional recurrence rates in patients with node-positive breast cancer","volume":"6","author":"Woodward","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnci\/djw259","article-title":"21-gene recurrence score and locoregional recurrence in node-positive\/ER-positive breast cancer treated with chemo-endocrine therapy","volume":"109","author":"Mamounas","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0013","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.2008.17.9291","article-title":"Lymphedema in breast cancer survivors: Incidence, degree, time course, treatment, and symptoms","volume":"27","author":"Norman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0014","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jnci\/djx148","article-title":"Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction","volume":"110","author":"Jagsi","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0016","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","article-title":"Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system","volume":"25","author":"Hudis","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0017","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10549-017-4619-4","article-title":"Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results","volume":"168","author":"Singh","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0018","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1200\/JCO.2005.06.178","article-title":"Population-based validation of the prognostic model ADJUVANT! for early breast cancer","volume":"23","author":"Olivotto","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0019","series-title":"AJCC Cancer Staging System","author":"Amin","year":"2017"},{"issue":"4","key":"10.1016\/j.ijrobp.2021.10.149_bib0020","doi-asserted-by":"crossref","first-page":"E134","DOI":"10.9778\/cmajo.20130017","article-title":"Stage, treatment and outcomes for patients with breast cancer in British Columbia in 2002: A population-based cohort study","volume":"1","author":"Davidson","year":"2013","journal-title":"CMAJ Open"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0021","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ijrobp.2020.07.2313","article-title":"Hypofractionated adjuvant radiation therapy is effective for patients with lymph node-positive breast cancer: A population-based analysis","volume":"108","author":"Koulis","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0022","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0023","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0024","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.radonc.2016.08.018","article-title":"Trends in use and outcome of postoperative radiotherapy following mastectomy: A population-based study","volume":"122","author":"Corradini","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0026","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"S\u00f8rlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0027","doi-asserted-by":"crossref","DOI":"10.1177\/1178223420977848","article-title":"Predictability of 21-gene recurrence score assay by using pathological and immunohistochemical parameters in breast cancer","volume":"14","author":"Alkushi","year":"2020","journal-title":"Breast Cancer (Auckl)"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0028","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1016\/j.prro.2016.08.009","article-title":"Postmastectomy radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update","volume":"6","author":"Recht","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib31","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.10.149_bib0029","doi-asserted-by":"crossref","first-page":"P3-07-01","DOI":"10.1158\/1538-7445.SABCS19-P3-07-01","article-title":"Breast cancer-specific mortality (BCSM) in patients age 50 years or younger with node-positive (N+) breast cancer (BC) treated based on the 21-gene assay in clinical practice","volume":"80","author":"Petkov","year":"2020","journal-title":"Cancer Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621030728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621030728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:59:48Z","timestamp":1759744788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301621030728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0360301621030728"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.10.149","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Regional Nodal Irradiation and Breast Cancer Recurrence-Free Interval for Patients With Low-Risk, Node-Positive Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.10.149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}